| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.2M | +38.6% |
| SG&A Expense | $6.0M | +79.4% |
| Operating Income | -$19.2M | -49.2% |
| Net Income | -$19.1M | -48.1% |
| EPS (Basic) | -$1.51 | +50.0% |
| EPS (Diluted) | -$1.51 | +50.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | +248.2% |
| Current Assets | $20.4M | +249.8% |
| Total Assets | $20.4M | +206.5% |
| Current Liabilities | $6.2M | +155.7% |
| Total Liabilities | $6.2M | +155.7% |
| Stockholders' Equity | $14.2M | +229.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.6M | -42.7% |
| Financing Cash Flow | $27.8M | +82.4% |